Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study

Figure 1

Kaplan-Meyer plot of cumulative proportion of patients remaining free from relapse over time from start of fingolimod therapy.